-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Endovascular therapy (EVT) is a highly impactful treatment for selected patients with acute ischemic stroke
(AIS) with large vessel occlusion (LVO) .
However, effective screening and implementation of EVT relies on professional competence, not every hospital caring for AIS patients can do it
.
In a previous study examining selected hospital subgroups, black patients were less likely to receive intravenous recombinant tissue-type plasma protein activator (IV tPA) and EVT compared with white patients
screening
To assess this question more completely, Youngran Kim et al.
of Harvard University used a full-sample dataset that captured all patients treated during the study period across the state, regardless of hospital type
.
They examined access to and utilization of EVT for AIS by ethnicity and validated their findings in an independent national sample
They conducted a retrospective, population-based study using the 2019 Texas Inpatient Public Use Data File
.
Acute ischemic stroke cases and EVT use were determined using diagnostic and procedural codes from the International Classification of Diseases, tenth revision (ICD-10)
diagnosis
They examined EVT use by race/ethnicity and performed patient- and hospital-level analyses
.
To validate the state-by-state findings, a patient-level analysis was performed using the 2017 national sample of hospitalized patients to obtain national estimates
Of the 40,814 acute ischemic stroke cases in Texas in 2019, 54% were white, 17% were black, and 21% were Hispanic
.
Black patients had similar EVT performance hospital admissions and more comprehensive stroke centers (CSCs) compared with white patients (EVT 62% vs 62%, P=0.
EVT rates did not differ between Hispanic and white patients
.
The lower EVT rate among black patients was consistent in the subgroup who arrived at an early time window and received intravenous recombinant tissue-type plasma protein activator (adjusted relative risk, 0.
Data from a nationwide sample confirmed the finding that black patients had less EVT use (adjusted relative risk, 0.
87 [0.
77-0.
98], P=0.
024)
.
The significance of this study lies in its findings: There were no differences in visits to hospitals or CSCs where EVT was performed; however, EVT use was lower in black patients
.
.
Original source:
Kim Y, Sharrief A, Kwak MJ, et al.
Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.
Stroke.
Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.
Stroke.
Leave a Comment